Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cubilin is a large, extracellular, endocytic receptor highly expressed in the apical membrane of ileal enterocytes and kidney proximal tubules, where it binds the intrinsic factor–vitamin B12 complex and mediates its internalization in a calcium-dependent manner through interaction with amnionless. Loss of Cubilin function results in severe vitamin B12 deficiency, contributing to diseases like Imerslund-Gräsbeck syndrome. Cubilin is also a multi-ligand receptor involved in reabsorption of various proteins. BtuB is an outer membrane, TonB-dependent transporter in Escherichia coli and related bacteria, highly specific for the uptake of vitamin B12 from the environment. Mutations in BtuB can render it non-functional, which blocks vitamin B12 transport in bacteria.
For Cubilin: Receptor-mediated endocytosis of vitamin B12–intrinsic factor complex. For BtuB: Facilitated transport of cobalamin across the outer membrane using the TonB-dependent active transport system.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cubilin (for mammalian systems, the vitamin B12–intrinsic factor receptor); BtuB (for E. coli and other Gram-negative bacteria, the outer membrane vitamin B12 receptor) (Cubn (for Cubilin in mammals); BtuB (in bacteria)).